Veerareddy, P.; Dao, N.; Yun, J.W.; Stokes, K.Y.; Disbrow, E.; Kevil, C.G.; Cvek, U.; Trutschl, M.; Kilgore, P.; Ramanathan, M.;
et al. Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. Pathophysiology 2022, 29, 570-582.
https://doi.org/10.3390/pathophysiology29030044
AMA Style
Veerareddy P, Dao N, Yun JW, Stokes KY, Disbrow E, Kevil CG, Cvek U, Trutschl M, Kilgore P, Ramanathan M,
et al. Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. Pathophysiology. 2022; 29(3):570-582.
https://doi.org/10.3390/pathophysiology29030044
Chicago/Turabian Style
Veerareddy, Pooja, Nhi Dao, Jungmi W. Yun, Karen Y. Stokes, Elizabeth Disbrow, Christopher G. Kevil, Urska Cvek, Marjan Trutschl, Philip Kilgore, Murali Ramanathan,
and et al. 2022. "Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses" Pathophysiology 29, no. 3: 570-582.
https://doi.org/10.3390/pathophysiology29030044
APA Style
Veerareddy, P., Dao, N., Yun, J. W., Stokes, K. Y., Disbrow, E., Kevil, C. G., Cvek, U., Trutschl, M., Kilgore, P., Ramanathan, M., Zivadinov, R., & Alexander, J. S.
(2022). Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. Pathophysiology, 29(3), 570-582.
https://doi.org/10.3390/pathophysiology29030044